“Cutting edge” innovation at MaRS
On November 27, Axela (a MaRS tenant and Venture Group client) was featured along with Dr. Alex Levin from Sick Children’s Hospital on a CTV Canada AM special series, “Canadians on the Cutting Edge.”
The interview highlights Axela’s dotLabâ„¢ System which detects protein biomarkers related to Shaken Baby Syndrome in emergency rooms. These markers may also be of value in the diagnosis of other spinal and brain injuries. Axela is working with collaborators at health research facilities across North America including McGill University, Johns Hopkins, the National Institutes of Health and others to help address key diagnostic challenges in diseases like cancer and cardiology.
Axela’s founder, Cynthia Goh, PhD., invented the core technology at the University of Toronto. Since then, the company has added significantly to its intellectual property portfolio through commercialization and licensing.
Be sure to check out the video: “Canadians on the Cutting Edge.”

Rocky Ganske is the President and CEO of Axela and has over 25 years of experience in diagnostics and health research. He has led Axela from a University technology to a revenue generating commercial enterprise.